Search Press releases Keywords From To 22 May 2006 New CIMZIA (TM) Data from PRECiSE Program Reinforce Robust Efficacy in Once-Monthly Treatment of Crohn's Disease and Consistent Tolerability Profile Read More 15 May 2006 European Commission Approves Keppra® for Use as Adjunctive Therapy in the Treatment of Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Read More 10 May 2006 UCB and Immunomedics announce worldwide development collaboration and license agreement for Epratuzumab Read More 28 Apr 2006 UCB Submits Marketing Authorisation Application in Europe for CIMZIATM, a New Crohn's Disease Therapy Read More 26 Apr 2006 UCB: Two European Regulatory Milestones for Keppra® Read More 24 Apr 2006 UCB transfers back to Recordati the rights for the sale of Corifeo® (Lercanidipine) in Germany Read More Pagination First page Previous page Previous … Page 183 Page 184 Page 185 Page 186 Current page 187 Page 188 Page 189 Page 190 Page 191 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
